Variant report
Variant | esv9802 |
---|---|
Chromosome Location | chr1:78834094-78835855 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PTGFR-1 | chr1:78834222-78834412 | NONHSAT004072 |
2 | lnc-PTGFR-1 | chr1:78834968-78835147 | NONHSAT004072 |
3 | lnc-PTGFR-1 | chr1:78834222-78834412 | ENSG00000237413.1 |
4 | lnc-PTGFR-1 | chr1:78834968-78835149 | ENSG00000237413.1 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185205292 | chr1:78834101-78834102 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190946210 | chr1:78834128-78834129 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544101370 | chr1:78834161-78834162 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182714226 | chr1:78834162-78834163 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6424768 | chr1:78834258-78834259 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs188229204 | chr1:78834259-78834260 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs540949610 | chr1:78834284-78834285 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs192795620 | chr1:78834290-78834291 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs532801087 | chr1:78834292-78834293 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs550765421 | chr1:78834318-78834319 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs574631489 | chr1:78834386-78834387 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs529781557 | chr1:78834439-78834440 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540324721 | chr1:78834444-78834445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs183470554 | chr1:78834448-78834449 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs560139660 | chr1:78834556-78834557 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114491443 | chr1:78834575-78834576 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552119128 | chr1:78834742-78834743 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11809460 | chr1:78834864-78834865 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs11809462 | chr1:78834898-78834899 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs556442616 | chr1:78834957-78834958 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569168794 | chr1:78835007-78835008 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs538182996 | chr1:78835010-78835011 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs574673276 | chr1:78835094-78835095 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs557945090 | chr1:78835143-78835144 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs577916935 | chr1:78835183-78835184 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs554743052 | chr1:78835191-78835192 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573260550 | chr1:78835198-78835199 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540284209 | chr1:78835226-78835227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563060799 | chr1:78835293-78835294 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534009679 | chr1:78835321-78835322 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565236711 | chr1:78835391-78835392 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6424769 | chr1:78835491-78835492 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs574086730 | chr1:78835522-78835523 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542989513 | chr1:78835559-78835560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs562591261 | chr1:78835563-78835564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187403084 | chr1:78835642-78835643 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145132433 | chr1:78835668-78835669 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12755166 | chr1:78835673-78835674 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192350331 | chr1:78835688-78835689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530211158 | chr1:78835691-78835692 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548349771 | chr1:78835692-78835693 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565107131 | chr1:78835724-78835725 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560008933 | chr1:78835758-78835759 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12023080 | chr1:78835761-78835762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527336312 | chr1:78835775-78835776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184768912 | chr1:78835830-78835831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189427929 | chr1:78835836-78835837 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs386508263 | chr1:78835838-78835839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Schizophrenia | 23813976 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:78832400-78837800 | Weak transcription | Pancreas | Pancrea |
2 | chr1:78833600-78837600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr1:78833800-78836800 | Enhancers | NHDF-Ad | bronchial |
4 | chr1:78833800-78837600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr1:78833800-78837600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr1:78834000-78834200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr1:78834000-78836200 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr1:78834200-78834800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr1:78834200-78835000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
10 | chr1:78834600-78837600 | Enhancers | HMEC | breast |
11 | chr1:78834600-78837800 | Enhancers | HSMM | muscle |
12 | chr1:78834800-78837600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr1:78834800-78837800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr1:78835000-78835400 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
15 | chr1:78835400-78835800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
16 | chr1:78835400-78837000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
17 | chr1:78835600-78837400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
18 | chr1:78835600-78837400 | Enhancers | Osteobl | bone |